2 weeks Ago By ABMN Staff
Medifast, Inc. ( NYSE:MED – Free Report ) – Zacks Research upped their FY2024 EPS estimates for shares of Medifast in a research note issued to investors on Monday, August 26th. Zacks Research analyst A.
Mohta now expects that the specialty retailer will post earnings per share of $1.87 for the year, up from their previous estimate of $1.33.
The consensus estimate for Medifast’s current full-year earnings is $1.15 per share. Zacks Research also issued estimates for Medifast’s Q1 2025 earnings at $0.
35 EPS, Q2 2025 earnings at $0.37 EPS, Q4 2025 earnings at $0.43 EPS, FY2025 earnings at $1.
53 EPS, Q1 2026 earnings at $0.48 EPS, Q2 2026 earnings at $0.50 EPS and FY2026 earnings at $2.
14 EPS. Medifast ( NYSE:MED – Get Free Report ) last issued its quarterly earnings data on Monday, August 5th. The specialty retailer reported $0.
92 EPS for the quarter, beating the consensus estimate of $0.36 by $0.56.
The business had revenue of $168.56 million during the quarter, compared to the consensus estimate of $160.44 million.
Medifast had a net margin of 3.81% and a return on equity of 25.77%.
During the same quarter in the prior year, the firm earned $2.77 EPS. Get Our Latest Stock Analysis on MED Medifast Stock Down 1.
3 % Shares of NYSE MED opened at $18.58 on Thursday. Medifast has a twelve month low of $17.
86 and a twelve month high of $86.89. The firm has a fifty day simple moving average of $19.
63 and a 200 day simple moving average of $27.83. The company has a market capitalization of $203.
27 million, a PE ratio of 3.00 and a beta of 1.15.
Institutional Inflows and Outflows Hedge funds have recently made changes to their positions in the business. nVerses Capital LLC grew its holdings in shares of Medifast by 54.5% during the second quarter.
nVerses Capital LLC now owns 1,700 shares of the specialty retailer’s stock valued at $37,000 after buying an additional 600 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in shares of Medifast by 53.1% during the fourth quarter.
Zurcher Kantonalbank Zurich Cantonalbank now owns 2,628 shares of the specialty retailer’s stock valued at $177,000 after buying an additional 911 shares during the last quarter. Quarry LP grew its holdings in shares of Medifast by 592.7% during the second quarter.
Quarry LP now owns 2,667 shares of the specialty retailer’s stock valued at $58,000 after buying an additional 2,282 shares during the last quarter. Swedbank AB purchased a new position in Medifast during the first quarter worth about $115,000. Finally, Triumph Capital Management purchased a new position in Medifast during the fourth quarter worth about $213,000.
95.51% of the stock is currently owned by institutional investors and hedge funds. Medifast Company Profile ( Get Free Report ) Medifast, Inc, through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific.
It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names. Featured Articles Receive News & Ratings for Medifast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medifast and related companies with MarketBeat.com's FREE daily email newsletter .
.
